Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,279
-18.31%
|
$501,505
$95.73 P/Share
|
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+32.91%
|
-
|
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
4,510
-12.72%
|
$428,450
$95.73 P/Share
|
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+28.51%
|
-
|
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-4.13%
|
$73,910
$95.73 P/Share
|
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,650
+12.34%
|
-
|
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,758
-20.99%
|
$1,117,010
$95.73 P/Share
|
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,748
+30.65%
|
-
|
|
May 28
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,736
-11.25%
|
$3,964,920
$95.73 P/Share
|
|
May 28
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,062
+22.23%
|
-
|
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
4,399
-13.99%
|
$417,905
$95.73 P/Share
|
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
13,256
+29.65%
|
-
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
686
-3.63%
|
$65,170
$95.11 P/Share
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,555
-7.61%
|
$147,725
$95.08 P/Share
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,241
+9.88%
|
$125,496
$56.57 P/Share
|
|
May 20
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
987
-4.43%
|
$93,765
$95.08 P/Share
|
|
May 20
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,604
-4.88%
|
$152,380
$95.08 P/Share
|
|
May 17
2024
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
587
+33.91%
|
-
|
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+13.63%
|
-
|
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-1.82%
|
$26,980
$95.73 P/Share
|
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,394
+18.77%
|
-
|
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-3.0%
|
$33,155
$95.73 P/Share
|
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,089
+11.44%
|
-
|
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.54%
|
$7,220
$95.73 P/Share
|
|
May 17
2024
|
Roy Galvin President, Global Plasma & BC |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+27.93%
|
-
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+21.94%
|
-
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-1.96%
|
$30,400
$95.73 P/Share
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
822
-4.79%
|
$77,268
$94.82 P/Share
|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,178
+11.28%
|
-
|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-2.28%
|
$63,555
$95.73 P/Share
|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,073
-3.53%
|
$101,935
$95.0 P/Share
|
|
May 17
2024
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,439
+20.38%
|
-
|
|
May 17
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,624
+5.23%
|
-
|
|
May 17
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,037
-1.59%
|
$383,515
$95.73 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
733
-4.49%
|
$70,368
$96.04 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-5.45%
|
$183,255
$95.47 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,410
+11.8%
|
$137,370
$57.6 P/Share
|
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
985
-3.14%
|
$94,560
$96.14 P/Share
|
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.4%
|
$41,924
$94.8 P/Share
|
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
770
-4.29%
|
$73,920
$96.14 P/Share
|
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-1.44%
|
$24,722
$94.8 P/Share
|
|
May 16
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-1.62%
|
$21,902
$94.8 P/Share
|
|
May 16
2024
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-2.65%
|
$32,994
$94.8 P/Share
|
|
May 16
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-0.74%
|
$179,258
$94.8 P/Share
|
|
May 16
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-2.66%
|
$29,892
$94.8 P/Share
|
|
May 15
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
241
-1.5%
|
$23,136
$96.49 P/Share
|
|
May 15
2024
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-11.59%
|
$7,008
$96.49 P/Share
|
|
May 15
2024
|
Roy Galvin President, Global Plasma & BC |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-4.5%
|
$20,544
$96.49 P/Share
|
|
May 15
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.29%
|
$39,936
$96.49 P/Share
|
|
May 15
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-1.4%
|
$24,768
$96.49 P/Share
|